Readmission Outcomes in Kidney Transplant Recipients With and Without Delayed Graft Function
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.08.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Rachana Punukollu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transplant Surgery, Mayo Clinic, Phoenix, Arizona. Hauptthemen laut MEDLINE: Kidney Transplantation, Patient Readmission, Delayed Graft Function. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Delayed graft function (DGF) is a common post-transplant event associated with increased resource utilization. As a center with experience in DGF, we aimed to assess differences in readmissions and post-transplant outcomes between patients with and without DGF. METHODS: This was a retrospective review of deceased donor kidney transplant recipients at Mayo Clinic Arizona between 2015 and 2020. Recipients with at least one early readmission following kidney transplantation were included in the study. Two groups were identified: (1) recipients with DGF who required early readmission and (2) recipients without DGF who required early readmission. RESULTS: Among recipients with DGF, 43.9% (n = 405) required early readmission compared to 29.1% (n = 179) without DGF (P < .0001). There were no differences in the initial hospital length of stay (P = .08), and most recipients in both groups only required a single readmission (61.7% vs 72.1%, P = .02). Recipients with DGF were more likely to have ≥2 readmissions (P = .02) and a higher total readmission rate (P = .006). Recipients with DGF who required readmission also required more outpatient clinic visits (P = .003). When comparing recipients with and without DGF who required readmission, there were no differences in patient (P = .22) or death-censored (P = .72) graft survival. When comparing patients with and without DGF requiring one versus ≥2 readmissions, there were no differences in patient survival (P = .15), however patients with DGF and ≥2 readmissions had lower death-censored graft survival (P = .001). CONCLUSIONS: Recipients with DGF are at increased risk of readmission. Transplant center-level changes to reduce readmissions and infections could have an important impact on DGF outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Transplant Surgery, Mayo Clinic, Phoenix, Arizona.
- Mayo Clinic Alix School of Medicine, Scottsdale, Arizona.
- Division of Anesthesiology, Mayo Clinic, Phoenix, Arizona.
- Division of Nephrology, Mayo Clinic, Phoenix, Arizona.
- Division of Transplant Surgery, Mayo Clinic, Phoenix, Arizona. Electronic address: jadlowiec.caroline@mayo.edu.
Zitieren
APA
Punukollu, R., Nica, A., Ohara, S., Kumm, K., Frasco, P. E., Budhiraja, P., Mathur, A., Heilman, R., & Jadlowiec, C. C. (2024). Readmission Outcomes in Kidney Transplant Recipients With and Without Delayed Graft Function. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.08.003
Vancouver
Punukollu R, Nica A, Ohara S, Kumm K, Frasco PE, Budhiraja P, et al. Readmission Outcomes in Kidney Transplant Recipients With and Without Delayed Graft Function. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.08.003
BibTeX
@article{Punukollu2024,
author = {Punukollu, Rachana and Nica, Alex and Ohara, Stephanie and Kumm, Kayla and Frasco, Peter E and Budhiraja, Pooja and Mathur, Amit and Heilman, Raymond and Jadlowiec, Caroline C},
title = {Readmission Outcomes in Kidney Transplant Recipients With and Without Delayed Graft Function},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.08.003}
}
EUVIMED